Topic prioritisation
Showing 1 to 2 of 2
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Subcutaneous olanzapine for treating schizophrenia [TSID12289] | Medicines evaluation | Not selected | |
| Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833] | None selected | Awaiting decision | TBC |